Brief: Immunoprecise Antibodies Says To Reschedule Financial Results And Recent Business Highlights Report To July 29
July 23 (Reuters) - Immunoprecise Antibodies Ltd
IPA.O :
* IMMUNOPRECISE ANTIBODIES TO RESCHEDULE FINANCIAL RESULTS
AND
RECENT BUSINESS HIGHLIGHTS REPORT FOR FOURTH QUARTER AND FISCAL
YEAR-END 2024
* IMMUNOPRECISE ANTIBODIES - TIME TO ALLOW AUDITORS TO
COMPLETE
VALUATION CALCULATIONS ON GOODWILL INTANGIBLE ASSETS; NEW
RELEASE DATE JULY 29
Source text for Eikon: ID:nBw2VNmNSa
Further company coverage: IPA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mindwalk Holdings
See all newsBrief: Mindwalk Holdings Corp. Announces Leadership Update
MindWalk Holdings Corp reports results for the quarter ended July 31 - Earnings Summary
Canada's MindWalk Q1 net loss widens on higher sales, marketing expenses
MindWalk Holdings Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: MindWalk Showcases Reefiq™ For Ai Drug Discovery At AMD Advancing Ai